Identification of extra lung water by lung ultrasound in patients for major abdominal surgery.

Phase 3

• Conditions: Health Condition 1: null- ASA i-III patients undergoing cytoreductive surgery and peritonectomy.

• Registration Number: CTRI/2016/12/007596
• Lead Sponsor: Rajiv Gandhi Cancer Institute and Research centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

All patients scheduled for cytoreductive surgery and HIPEC(hyperthermic intraperitoneal chemotherpy) for major abdominal surgery.

Exclusion Criteria

Contraindication to femoral artery cathertization (infection at site of procedure, significant valvular heart disease, severe peripheral vascular disease, aortic aneurysm).

Cardiac arrhythmias.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quantification of Extravascular Lung water volume by transpulmonary thermodiluation and lung ultrasound methodTimepoint: After Induction, before HIPEC and after HIPEC

Secondary Outcome Measures

Name	Time	Method
Quantification of Extravascular Lung water volume by transpulmonary thermodilution and Lung Ultrasound,ABG, CXR findingsTimepoint: 6 hours in post operative period